Bluejay Diagnostics, Inc.
BJDX- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001704287
In the last 90 days, Bluejay Diagnostics, Inc. insiders filed 1 open-market purchase and 1 sale; 8 institutions reported holding it in 13F filings for Q2 2026, worth $259.3K in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Bluejay Diagnostics, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 4 | 9 | +5 |
| Shares | 93.9K | 168.4K | +74.6K (+79.5%) |
| Value | $142.7K | $112.3K | −$30.4K (−21.3%) |
New holders (7)
Institutions that held Bluejay Diagnostics, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 65,000 | $43.4K | 0.00% |
| Citadel Advisors LLC | 41,794 | $27.9K | 0.00% |
| Renaissance Technologies LLC | 32,100 | $21.4K | 0.00% |
| Two Sigma Securities, LLC | 14,351 | $9.57K | 0.00% |
| Geode Capital Management, LLC | 10,256 | $6.84K | 0.00% |
| L1 Global Manager Pty Ltd | 483 | $226 | 0.00% |
| Meteora Capital, LLC | 1 | $1 | 0.00% |
Sold out (2)
Institutions that held Bluejay Diagnostics, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| DRW Securities, LLC | 59,767 | $90.8K |
| Sabby Management, LLC | 29,628 | $45.0K |